GlobeNewswire: InSilico Medicine, Inc. Contains the last 10 of 13 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:42:16ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/09/09/767181/10148808/en/Geroprotectors-org-the-First-Online-Database-of-Life-Extending-Drugs-Launched-by-Longevity-Scientists.html?f=22&fvtc=4&fvtv=22015Geroprotectors.org, the First Online Database of Life-Extending Drugs, Launched by Longevity Scientists2015-09-09T17:17:21Z<![CDATA[Researchers from Insilico Medicine, Inc. and an international team of anti-aging scientists have created Geroprotectors.org, the first website to address the public's growing interest in geroprotectors, drugs developed to fight specific diseases but delivered the unexpected side effect of prolonging life. BALTIMORE, Md., Sept. 9, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Fueled by a booming market for longevity products and medicine, an international team of scientists has launched a database showcasing the latest research on geroprotectors at ]]>https://www.globenewswire.com/news-release/2015/08/18/761518/10146384/en/Insilico-Medicine-Inc-Announces-Collaboration-with-Baseport-Research-Laboratories-to-Accelerate-Deep-Learning-Programs-in-Cancer-and-Aging-Bioinformatics.html?f=22&fvtc=4&fvtv=22015Insilico Medicine, Inc. Announces Collaboration with Baseport Research Laboratories to Accelerate Deep Learning Programs in Cancer and Aging Bioinformatics2015-08-18T15:02:38Z<![CDATA[Insilico Medicine and Baseport Research announce a collaboration in storage solutions for Deep Learning BALTIMORE, Md., Aug. 18, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Insilico Medicine Inc., a company utilizing neural network based Deep Learning for drug discovery and repurposing targeting cancer and age-related diseases, announced it will be hosting the first commercial installation of miniature centi-terabyte scale desktop storage servers from BasePort Research Laboratories. The companies will collaborate on customizing the Linux based server software to optimize the system for the massive data storage and rapid retrieval requirements needed for Insilico Medicine's investigations into clinical oncology, discovery and personalized medicine projects.]]>https://www.globenewswire.com/news-release/2015/07/13/751621/10141467/en/Insilico-Medicine-Inc-to-Utilize-Deep-Learning-for-Drug-Repurposing-and-Discovery-in-Cancer-and-Age-Related-Diseases.html?f=22&fvtc=4&fvtv=22015Insilico Medicine, Inc. to Utilize Deep Learning for Drug Repurposing and Discovery in Cancer and Age-Related Diseases2015-07-13T17:04:43Z<![CDATA[The machine-learning technique known as deep learning, which has shown impressive results in voice and image recognition, has been adopted by the leading bioinformatics company focusing on cancer and aging as part of its DeepPharma platform. BALTIMORE, Md., July 13, 2015 (GLOBE NEWSWIRE) -- via PRWEB - A machine-learning technique which borrows some of its principles from the brain and gives computers the ability to recognize speech and categorize images is also being utilized in the ongoing fight against cancer and other age-related diseases. Insilico Medicine, a ]]>https://www.globenewswire.com/news-release/2015/06/03/741865/10137183/en/Baltimore-Poised-to-Become-a-World-Leading-Hub-of-Multi-Billion-Dollar-Bioinformatics-Industry.html?f=22&fvtc=4&fvtv=22015Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry2015-06-03T14:44:54Z<![CDATA[Local Scientists Predict Baltimore will become a leading technology epicenter in the field of bioinformatics, a fast-growing industry in which computer technology is used to analyze complex biological data to fight aging and age-related diseases, such as cancer, says InSilico Medicine, Inc. BALTIMORE, Md., June 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - On the heels of a report predicting ]]>https://www.globenewswire.com/news-release/2015/04/22/727137/10130182/en/In-the-First-Bioinformatics-Hackathon-Computer-Scientists-Meeting-in-Russia-Use-their-Computer-Skills-to-Fight-Deadly-Diseases.html?f=22&fvtc=4&fvtv=22015In the First Bioinformatics Hackathon, Computer Scientists Meeting in Russia Use their Computer Skills to Fight Deadly Diseases2015-04-22T14:02:36Z<![CDATA[InSilico Medicine, Inc.: Popularized in the movie "The Social Network", hackathons are marathon coding festivals where software developers and scientists collaborate, usually to solve a business or software problem. In a 48-hour hackathon in Moscow, computer programmers faced a different challenge – use their computer skills to help find a cure for cancer and other age-related diseases. MOSCOW, Russia, April 22, 2015 (GLOBE NEWSWIRE) -- via PRWEB - In an intense, caffeine-fueled 48-hour brainstorming session, 100 computer programmers met in Moscow last week to compete in "GeneHack 2015", a hackathon in which competitors used their computer programming skills to organize, analyze and visualize reams of biological data. Their ultimate goal – leverage their computer skills to unlock the genetic code of deadly diseases like cancer and Alzheimer's disease and extend the human lifespan.]]>https://www.globenewswire.com/news-release/2015/04/15/724793/10129041/en/Cancer-Fighting-and-Aging-Fighting-Scientists-Announce-Joint-Discovery-in-the-War-against-Colorectal-Cancer.html?f=22&fvtc=4&fvtv=22015Cancer-Fighting and Aging-Fighting Scientists Announce Joint Discovery in the War against Colorectal Cancer2015-04-15T14:02:48Z<![CDATA[Two innovative medical technology companies, InSilico Medicine, Inc. and Champions Oncolology, Inc., have discovered what may prove to be a "green light" tool in colon cancer treatment; a tool that helps doctors choose the most promising path to treat a patient when so many other treatment options are available. The discovery may lead to more effective treatment of colon cancer. BALTIMORE, Md., April 15, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and the second leading cause of cancer deaths in the United States. More than 50,000 people die of CRC each year and almost half of all newly diagnosed patients are in an advanced stage of cancer (metastatic CRC) when they are first diagnosed.]]>https://www.globenewswire.com/news-release/2015/03/27/719718/10126673/en/InSilico-Medicine-Inc-Stands-Out-from-High-Tech-Startups-at-2015-GPU-Conference.html?f=22&fvtc=4&fvtv=22015InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference2015-03-27T14:04:01Z<![CDATA[Focused on Extending the Human Lifespan, the bioinformatics company is one of 12 rising star technology companies recognized as the most promising GPU-fueled Startup SAN JOSE, Calif., March 27, 2015 (GLOBE NEWSWIRE) -- via PRWEB - While deep learning was the topic of many conversations at last week's ]]>https://www.globenewswire.com/news-release/2015/03/12/714749/10124507/en/Insilico-Medicine-utilizing-high-performance-computing-to-combat-aging-and-age-related-diseases-selected-for-NVIDIA-GTC-Contest-Finals.html?f=22&fvtc=4&fvtv=22015Insilico Medicine utilizing high-performance computing to combat aging and age-related diseases selected for NVIDIA GTC Contest Finals2015-03-12T14:08:19Z<![CDATA[The Baltimore MD informatics company is one of 12 rising star technology players that will take the stage to compete for a $100,000 prize and a shot being recognized as the most promising GPU-fueled company SAN JOSE, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- via PRWEB - While deep learning will be the topic of many conversation at next week's 2015 GPU technology conference, one startup will talk passionately about using high-performance NVIDIA GPU technology to fight cancer, age-related diseases and aging itself.]]>https://www.globenewswire.com/news-release/2015/02/16/706674/10120305/en/Pioneering-Longevity-Researcher-Insilico-Medicine-Inc-Takes-Top-Prize-at-PMWC-2015.html?f=22&fvtc=4&fvtv=22015Pioneering Longevity Researcher Insilico Medicine, Inc. Takes Top Prize at PMWC 20152015-02-16T15:02:17Z<![CDATA[As billions pour into biotech and medical research firms looking for life-extending medications, venture capitalists at the Personalized World Medicine Conference give Insilico Medicine, Inc. the "Most Promising Company" Award for 2015 BALTIMORE, Feb. 16, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Insilico Medicine, Inc., a ]]>https://www.globenewswire.com/news-release/2014/12/09/689833/10111626/en/Nobel-Laureate-Joins-the-Scientific-Advisory-Board-of-Insilico-Medicine-Inc-in-Combatting-Aging-and-Age-Related-Diseases.html?f=22&fvtc=4&fvtv=22015Nobel Laureate Joins the Scientific Advisory Board of Insilico Medicine, Inc. in Combatting Aging and Age-Related Diseases2014-12-09T15:03:13Z<![CDATA[2013 Nobel Laureate Michael Levitt is Insilico Medicine's latest Scientific Advisory Board addition in the pursuit of working interventions towards aging and aging-related disease. United with the board's current expertise, Dr. Levitt's background in computational biology will facilitate the company's effort to achieve novel drug discovery and personalized medicine. BALTIMORE, Md., Dec. 9, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Today Insilico Medicine, Inc. is announcing Michael Levitt, Nobel Prize Winner in Chemistry, as an addition to its Scientific Advisory Board.]]>